You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • FRI0214 Long-term efficacy and safety of sirukumab in patients with active rheumatoid arthritis despite anti-tumor necrosis factor therapy: results of the randomized, phase 3 sirround-t study

Article metrics

Article menu

Download PDFPDF

Poster Presentations
Rheumatoid arthritis - other biologic treatment
FRI0214 Long-term efficacy and safety of sirukumab in patients with active rheumatoid arthritis despite anti-tumor necrosis factor therapy: results of the randomized, phase 3 sirround-t study
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 20172801
Jul 20173802
Aug 20174202
Sep 20174002
Oct 20172003
Nov 20172201
Dec 20171200
Jan 20182807
Feb 20181401
Mar 20181201
Apr 2018400
May 2018200
Jun 20181000
Jul 2018800
Aug 20181000
Sep 2018800
Oct 2018400
Nov 2018802
Dec 2018801
Jan 2019600
Feb 2019401
Mar 2019603
Apr 2019202
May 2019403
Jun 2019601
Jul 2019804
Aug 2019401
Sep 2019801
Oct 2019801
Nov 2019202
Dec 20191000
Jan 2020400
Feb 2020903
Mar 2020401
Apr 2020200
May 20201002
Jun 20201001
Jul 2020800
Aug 2020505
Sep 20201301
Oct 2020702
Nov 2020200
Dec 2020201
Jan 2021001
Feb 2021400
Mar 2021405
Apr 2021402
May 2021302
Jun 2021003
Jul 2021001
Aug 2021002
Sep 2021001
Oct 20214018
Nov 20212014
Dec 20211401
Jan 2022600
Feb 2022602
Mar 2022201
Apr 2022800
May 20221406
Jun 2022602
Jul 2022800
Aug 20221807
Sep 2022804
Oct 2022805
Nov 2022607
Dec 20221001
Jan 2023602
Feb 2023301
Mar 2023800
Apr 2023001
May 2023002
Jun 2023201
Jul 2023204
Aug 2023001
Nov 2023201
Dec 20231001
Jan 2024401
Feb 2024201
Mar 2024208
Total6380167